202 related articles for article (PubMed ID: 36247015)
1. The MASTL-ENSA-PP2A/B55 axis modulates cisplatin resistance in oral squamous cell carcinoma.
Gouttia OG; Zhao J; Li Y; Zwiener MJ; Wang L; Oakley GG; Peng A
Front Cell Dev Biol; 2022; 10():904719. PubMed ID: 36247015
[TBL] [Abstract][Full Text] [Related]
2. The MASTL/PP2A cell cycle kinase-phosphatase module restrains PI3K-Akt activity in an mTORC1-dependent manner.
Sanz-Castillo B; Hurtado B; Vara-Ciruelos D; El Bakkali A; Hermida D; Salvador-Barbero B; Martínez-Alonso D; González-Martínez J; Santiveri C; Campos-Olivas R; Ximénez-Embún P; Muñoz J; Álvarez-Fernández M; Malumbres M
EMBO J; 2023 Jan; 42(2):e110833. PubMed ID: 36354735
[TBL] [Abstract][Full Text] [Related]
3. The Cell Cycle Checkpoint System MAST(L)-ENSA/ARPP19-PP2A is Targeted by cAMP/PKA and cGMP/PKG in Anucleate Human Platelets.
Kumm EJ; Pagel O; Gambaryan S; Walter U; Zahedi RP; Smolenski A; Jurk K
Cells; 2020 Feb; 9(2):. PubMed ID: 32085646
[TBL] [Abstract][Full Text] [Related]
4. PP2A/B55 and Fcp1 regulate Greatwall and Ensa dephosphorylation during mitotic exit.
Hégarat N; Vesely C; Vinod PK; Ocasio C; Peter N; Gannon J; Oliver AW; Novák B; Hochegger H
PLoS Genet; 2014 Jan; 10(1):e1004004. PubMed ID: 24391510
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic relevance of the PP2A-B55 inhibitory kinase MASTL/Greatwall in breast cancer.
Álvarez-Fernández M; Sanz-Flores M; Sanz-Castillo B; Salazar-Roa M; Partida D; Zapatero-Solana E; Ali HR; Manchado E; Lowe S; VanArsdale T; Shields D; Caldas C; Quintela-Fandino M; Malumbres M
Cell Death Differ; 2018 May; 25(5):828-840. PubMed ID: 29229993
[TBL] [Abstract][Full Text] [Related]
6. MASTL(Greatwall) regulates DNA damage responses by coordinating mitotic entry after checkpoint recovery and APC/C activation.
Wong PY; Ma HT; Lee HJ; Poon RY
Sci Rep; 2016 Feb; 6():22230. PubMed ID: 26923777
[TBL] [Abstract][Full Text] [Related]
7. A first generation inhibitor of human Greatwall kinase, enabled by structural and functional characterisation of a minimal kinase domain construct.
Ocasio CA; Rajasekaran MB; Walker S; Le Grand D; Spencer J; Pearl FM; Ward SE; Savic V; Pearl LH; Hochegger H; Oliver AW
Oncotarget; 2016 Nov; 7(44):71182-71197. PubMed ID: 27563826
[TBL] [Abstract][Full Text] [Related]
8. ENSA and ARPP19 differentially control cell cycle progression and development.
Hached K; Goguet P; Charrasse S; Vigneron S; Sacristan MP; Lorca T; Castro A
J Cell Biol; 2019 Feb; 218(2):541-558. PubMed ID: 30626720
[TBL] [Abstract][Full Text] [Related]
9. The Oncogenic Functions of MASTL Kinase.
Marzec K; Burgess A
Front Cell Dev Biol; 2018; 6():162. PubMed ID: 30555827
[TBL] [Abstract][Full Text] [Related]
10. Greatwall kinase at a glance.
Castro A; Lorca T
J Cell Sci; 2018 Oct; 131(20):. PubMed ID: 30355803
[TBL] [Abstract][Full Text] [Related]
11. Dephosphorylation of Plk1 occurs through PP2A-B55/ENSA/Greatwall pathway during mitotic DNA damage recovery.
Kim SY; Hyun SY; Jang YJ
Cell Cycle; 2019 May; 18(10):1154-1167. PubMed ID: 31072185
[TBL] [Abstract][Full Text] [Related]
12. Greatwall dephosphorylation and inactivation upon mitotic exit is triggered by PP1.
Ma S; Vigneron S; Robert P; Strub JM; Cianferani S; Castro A; Lorca T
J Cell Sci; 2016 Apr; 129(7):1329-39. PubMed ID: 26906418
[TBL] [Abstract][Full Text] [Related]
13. Regulation of α-endosulfine, an inhibitor of protein phosphatase 2A, by multisite phosphorylation.
Mochida S
FEBS J; 2014 Feb; 281(4):1159-69. PubMed ID: 24354984
[TBL] [Abstract][Full Text] [Related]
14. Mastl kinase, a promising therapeutic target, promotes cancer recurrence.
Wang L; Luong VQ; Giannini PJ; Peng A
Oncotarget; 2014 Nov; 5(22):11479-89. PubMed ID: 25373736
[TBL] [Abstract][Full Text] [Related]
15. The ATM-E6AP-MASTL axis mediates DNA damage checkpoint recovery.
Li Y; Wang F; Li X; Wang L; Yang Z; You Z; Peng A
bioRxiv; 2023 May; ():. PubMed ID: 36865136
[TBL] [Abstract][Full Text] [Related]
16. Endosulfine alpha maintains spindle pole integrity by recruiting Aurora A during mitosis.
Kim S; Jun K; Kim YH; Jung KY; Oh JS; Kim JS
BMC Cancer; 2023 Dec; 23(1):1263. PubMed ID: 38129815
[TBL] [Abstract][Full Text] [Related]
17. Greatwall-Endosulfine: A Molecular Switch that Regulates PP2A/B55 Protein Phosphatase Activity in Dividing and Quiescent Cells.
García-Blanco N; Vázquez-Bolado A; Moreno S
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835586
[TBL] [Abstract][Full Text] [Related]
18. The ATM-E6AP-MASTL axis mediates DNA damage checkpoint recovery.
Li Y; Wang F; Li X; Wang L; Yang Z; You Z; Peng A
Elife; 2023 Sep; 12():. PubMed ID: 37672026
[TBL] [Abstract][Full Text] [Related]
19. MASTL: A novel therapeutic target for Cancer Malignancy.
Fatima I; Singh AB; Dhawan P
Cancer Med; 2020 Sep; 9(17):6322-6329. PubMed ID: 32692487
[TBL] [Abstract][Full Text] [Related]
20. Fcp1 phosphatase controls Greatwall kinase to promote PP2A-B55 activation and mitotic progression.
Della Monica R; Visconti R; Cervone N; Serpico AF; Grieco D
Elife; 2015 Dec; 4():. PubMed ID: 26653855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
